A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/517 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2601740
The invention relates to the use of selected EGFR kinase inhibitors, especially selected quinazolines, quinolines, and pyrimidopyrimidines, for treating nasal polyposis and chronic rhinosinusitis.
L'invention concerne l'utilisation d'inhibiteurs de kinase EGFR sélectionnés, notamment de quinazolines, de quinolines et de pyrimido-pyrimidines sélectionnées, pour traiter la polypose nasale et la rhino-sinusite chronique.
Disse Bernd
Jung Birgit
Pohl Gerald
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Use of tyrosine kinase inhibitors for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tyrosine kinase inhibitors for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tyrosine kinase inhibitors for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1630114